Tag: AmplifyBio

Cell and Gene Therapy, Industry

AmplifyBio Expands Cell Therapy Characterization, Fills Gap in Preclinical Development

March 16, 2023

Via: Contract Pharma

AmplifyBio, a preclinical contract research organization (CRO), intends to build on discovery and characterization capabilities with the purchase of assets, including a site and a team of TCR-based drug development experts from PACT Pharma late last year. In a statement, […]

Mergers and Acquisitions

Battelle, AmplifyBio, Andelyn Biosciences Win Research Contract

February 8, 2023

Via: Contract Pharma

Battelle, Amplify, and Andelyn Biosciences, have won a seat on an eight-year, $149 million indefinite delivery, indefinite quantity (IDIQ) contract vehicle for the National Institute of Neurological Disorders and Stroke. As one of the prime contractors on the multi-award IDIQ, […]